Eton Pharmaceutcials Inc (ETON) Stock Price, Quote & News

Company Profile

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developi...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 847 787 7361

Website: www.etonpharma.com

Address:

21925 W. Field Parkway, Suite 235, Deer Park, United States

BullDonald Jan. 16 at 2:58 PM

$ETON Finally Reversed.... Lets see 25 !!

0 · Reply

BullDonald Jan. 15 at 9:19 PM

$ETON what the !! Move

0 · Reply

CFontina Jan. 15 at 3:58 PM

$ETON too timid to short, but quite confident it's heading to $12, if not $10, at which point I will reload. Has been a wonderful performer, but the valuation has outgrown the fundamentals and very few meaningful catalysts on the horizon.

0 · Reply

CharlieeMungerTWITS Jan. 15 at 12:55 PM

$ETON WIN WIN WIN

0 · Reply

Drashkawisha Jan. 15 at 6:28 AM

$ETON Yesterday: CEO "sells" shares (automatically) to cover taxes on a grant. Today: Director Casamento files Form 4 showing the actual grant details. Key takeaway: It’s simply annual grant season for the Board. No one is bailing. Even better? The strike price is set at $15.47. Management needs a breakout just as much as we do. The setup for the Feb 25th catalyst remains flawless.

0 · Reply

Happy_Feet19 Jan. 15 at 1:11 AM

$ETON Mark your calendar! 📅 FDA's virtual #rarediseaseday is February 23, 2026. Together, we're prioritizing accelerating medical products for rare diseases and ensuring patient perspectives guide our decisions. Every rare disease matters. x.com/us_fda/status/2011440... Note: CNBC launched “CNBC Cures” to cover Rare Disease programs. cnbc.com/amp/2026/01/08/cnb... Bullish

0 · Reply

frontiere Jan. 14 at 8:12 PM

$ETON Eton Pharma ref=$15.49 rare dz spec - NO pstn now but watching closely - $HROW Harrow Health spinout - buying levels on chart + revs / fundie growing but hiccup right now maybe temporary - excellent summary below 👇 - long term bullish but short term want to avoid being early - 👍 will look to start buying when weekly candles turn green like so

0 · Reply

TimeForBio Jan. 14 at 5:29 PM

$ETON Should move above $20 after approval. Great company

1 · Reply

TimeForBio Jan. 14 at 5:06 PM

$ETON Started a position

0 · Reply

Drashkawisha Jan. 14 at 4:55 PM

$ETON Regarding the CEO sale filing: This is a standard "Sell-to-Cover" transaction. Executives received stock grants (bullish incentive), and the system automatically sold a portion to cover the immediate tax liability. If he were actually dumping ahead of the FDA decision, he would be selling his core position, not just the tax portion of a new grant. Thesis remains unchanged. Eyes on the prize (PDUFA

0 · Reply

Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th

Nov 12, 2025, 4:30 PM EST - 2 months ago

Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th

Nov 6, 2025, 11:16 PM EST - 2 months ago

Eton Pharmaceuticals, Inc. (ETON) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:05 PM EST - 2 months ago

Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results

Oct 23, 2025, 4:30 PM EDT - 3 months ago

Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

Aug 20, 2025, 6:50 AM EDT - 5 months ago

Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference

Aug 8, 2025, 3:27 PM EDT - 5 months ago

Eton Pharmaceuticals, Inc. (ETON) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 5:02 AM EDT - 5 months ago

Eton Pharmaceuticals: Growth At A Reasonable Price, Or Maybe Even Better With Options

Aug 7, 2025, 4:05 PM EDT - 5 months ago

Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results

Jul 28, 2025, 7:00 AM EDT - 6 months ago

Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025

Jul 15, 2025, 9:33 AM EDT - 6 months ago

Eton Pharma Near Term Catalysts Vanish

Jul 8, 2025, 6:50 AM EDT - 6 months ago

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)

Jun 27, 2025, 6:50 AM EDT - 7 months ago

Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes

Jun 6, 2025, 5:26 PM EDT - 8 months ago

Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside

May 29, 2025, 12:42 PM EDT - 8 months ago

FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue

May 28, 2025, 5:28 PM EDT - 8 months ago

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

May 21, 2025, 2:57 AM EDT - 8 months ago

Eton Pharmaceuticals Set To Dominate Orphan Drug Niche

May 14, 2025, 4:30 PM EDT - 8 months ago

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

May 13, 2025, 10:40 PM EDT - 8 months ago

Eton Pharmaceuticals, Inc. (ETON) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:01 PM EDT - 8 months ago

Eton Pharmaceuticals Reports First Quarter 2025 Financial Results

May 1, 2025, 4:30 PM EDT - 9 months ago

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

Apr 28, 2025, 6:50 AM EDT - 9 months ago

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)

Apr 1, 2025, 7:00 AM EDT - 10 months ago

Eton Pharmaceuticals Out-Licenses International Rights to Increlex®

Mar 25, 2025, 2:30 AM EDT - 10 months ago

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program

Mar 18, 2025, 7:42 PM EDT - 10 months ago

Eton Pharmaceuticals, Inc. (ETON) Virtual Investor Day and Q4 2024 Earnings Call Transcript

Mar 18, 2025, 6:50 AM EDT - 10 months ago

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

Mar 14, 2025, 6:50 AM EDT - 11 months ago

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

Mar 4, 2025, 10:00 AM EST - 11 months ago

Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®

Mar 4, 2025, 6:50 AM EST - 11 months ago

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

Mar 3, 2025, 6:50 AM EST - 11 months ago

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

Feb 7, 2025, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600

Feb 6, 2025, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400

Jan 3, 2025, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

Dec 20, 2024, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

Dec 3, 2024, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer

Nov 25, 2024, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)

Nov 12, 2024, 8:01 PM EST - 1 year ago

Eton Pharmaceuticals, Inc. (ETON) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:01 PM EST - 1 year ago

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:30 PM EST - 1 year ago

Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Oct 3, 2024, 6:30 AM EDT - 1 year ago

Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen

Aug 22, 2024, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 11, 2024, 8:15 AM EDT - 1 year ago

Eton Pharmaceuticals, Inc. (ETON) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:01 PM EDT - 1 year ago

Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results

Jul 30, 2024, 5:30 PM EDT - 1 year ago

Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Jul 15, 2024, 4:05 PM EDT - 1 year ago

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

May 11, 2024, 9:34 AM EDT - 1 year ago

Eton Pharmaceuticals, Inc. Q1 2024 Earnings Call Transcript

May 9, 2024, 4:01 PM EDT - 1 year ago

Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

May 1, 2024, 4:05 PM EDT - 1 year ago

Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference

Apr 30, 2024, 7:00 AM EDT - 1 year ago

Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

Apr 29, 2024, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

BullDonald Jan. 16 at 2:58 PM

$ETON Finally Reversed.... Lets see 25 !!

0 · Reply

BullDonald Jan. 15 at 9:19 PM

$ETON what the !! Move

0 · Reply

CFontina Jan. 15 at 3:58 PM

0 · Reply

CharlieeMungerTWITS Jan. 15 at 12:55 PM

$ETON WIN WIN WIN

0 · Reply

Drashkawisha Jan. 15 at 6:28 AM

0 · Reply

Happy_Feet19 Jan. 15 at 1:11 AM

0 · Reply

frontiere Jan. 14 at 8:12 PM

0 · Reply

TimeForBio Jan. 14 at 5:29 PM

$ETON Should move above $20 after approval. Great company

1 · Reply

TimeForBio Jan. 14 at 5:06 PM

$ETON Started a position

0 · Reply

Drashkawisha Jan. 14 at 4:55 PM

0 · Reply

BullDonald Jan. 13 at 4:19 PM

$ETON Volume is low AF. as all ways.

0 · Reply

TGains Jan. 12 at 3:18 PM

$ETON guys sell me some shares, my Order is not going trough

0 · Reply

CharlieeMungerTWITS Jan. 9 at 11:16 PM

$ETON

0 · Reply

TGains Jan. 9 at 5:01 PM

$ETON started a position here

1 · Reply

Drashkawisha Jan. 9 at 4:28 PM

$AQST all- $OCUL- nice pre data run $ETON nice bounce from here pre Pdufa run up

1 · Reply

BullDonald Jan. 9 at 3:24 PM

$ETON ADDED 4K more shares ! Locked and Loaded. What a dead Board thoug, feels like you logged in into a outdate MMO games

0 · Reply

BullDonald Jan. 9 at 1:53 PM

$ETON i am Amazed , i should have made a diffrent wish 🤣

0 · Reply

badgermobile Jan. 9 at 3:24 AM

$ETON focus on Rare diseases and JPMC next week healthcare and ETON will roll

0 · Reply

BullDonald Jan. 8 at 11:49 PM

$ETON Adding Time. Give me 16

0 · Reply

Dbarnyard Jan. 7 at 5:40 PM

$ETON priced to perfection...and beyond. Still holding a small long position, but honestly think it's heading back to $10-12 this year.

1 · Reply

BullDonald Jan. 6 at 8:06 PM

$ETON Added !

1 · Reply

CharlieeMungerTWITS Jan. 6 at 12:05 PM

$ETON buy every dip to $16

0 · Reply

Market Cap	413.27M
Revenue (ttm)	39.01M
Net Income (ttm)	-3.82M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	15.44
Profit Margin	-9.79%
Debt to Equity Ratio	1.31

Volume	247,900
Avg Vol	271,338
Day's Range	N/A - N/A
Shares Out	26.82M
Stochastic %K	10%
Beta	1.18
Analysts	Strong Sell
Price Target	$30.00